News & Articles

Is Your Newly FDA-Approved Drug Eligible for Patent Term Extension?

We have recently spent some time determining whether a patent covering a drug which was newly approved New Drug Application (NDA) by the FDA, was eligible for patent term extension (“PTE”). The drug in question was the free base of the previously FDA approved salt. Under 35 U.S.C. 156, the term of a patent that claims “a […]

Continue Reading →